EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Eur J Cardiothorac Surg 2008;34:1262-1264. doi:10.1016/j.ejcts.2008.09.001
Copyright © 2008, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Nouman U. Khan
Rajesh Shah
Nizar Yonan
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khan, N. U.
Right arrow Articles by Yonan, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Khan, N. U.
Right arrow Articles by Yonan, N.
Related Collections
Right arrow Lung - transplantation

Case reports

Early experience with the Levitronix Centrimag® device for extra-corporeal membrane oxygenation following lung transplantation

Nouman U. Khan*, Mohamed Al-Aloul, Rajesh Shah, Nizar Yonan

Department of Cardiothoracic Transplant, Wythenshawe Hospital, Manchester M23 9LT, UK

Received 24 April 2008; received in revised form 26 August 2008; accepted 1 September 2008.

* Corresponding author. Address: Department of Heart and Lung Transplant, University Hospital of South Manchester NHS Foundation Trust, Wythenshawe Hospital, Manchester M23 9LT, UK. Tel.: +44 161 291 2092; fax: +44 161 291 2091. (Email: n_u_khan{at}hotmail.com).

Extra-corporeal membrane oxygenation (ECMO) is accepted as a salvage therapy to treat life-threatening complications following lung transplantation such as primary graft dysfunction, acute rejection or airway dehiscence. Levitronix Centrimag® (Levitronix LLC, Waltham, MA) is a centrifugal pump that consists of a magnetically levitated bearing-less rotor designed to reduce blood friction. ECMO using the Levitronix Centrimag® pump may be an ideal medium-term support for lung transplant recipients suffering these serious complications. We describe our early experience of using ECMO with Levitronix Centrimag® device and the Hilite hollow fibre membrane oxygenator (Medos Hilite® LT, Medos Medizintechnik AG) in three cases following lung transplantation. The device is technically easy to implant and manage with a low complication rate on minimal anticoagulation.

Key Words: Levitronix Centrimag® • Extra-corporeal membrane oxygenation • Lung transplantation






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.